Global Biomarkers Market to Reach $173.8 Billion by 2030, Driven by Personalized Medicine, Drug Development, and Diagnostics
Overview Biomarkers, or biological markers, are measurable indicators of biological states or conditions. They are widely used in diagnostics, disease monitoring, and drug development to assess disease progression and treatment effects. Biomarkers include molecules, genes, proteins, and other substances found in tissues, blood, or body fluids. Their importance spans multiple applications, including companion diagnostics, personalized medicine, and clinical research. With advancements in imaging technologies, biomarkers help healthcare professionals visualize data, design effective treatment plans, and identify therapeutic targets. The global biomarkers market , valued at $81.7 billion in 2024 , is projected to reach $173.8 billion by 2030 , growing at a CAGR of 13.4% from 2024 to 2030. This growth is fueled by an increasing incidence of chronic diseases, rising demand for precision medicine, and technological advancements in genomics, proteomics, and high-throughput screening. M...